Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies (Q58863453)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Preparation of pneumococcal capsular polysaccharide-protein conjugate vaccines utilizing new fragmentation and conjugation technologies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Gunilla Källenius

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

S B Svenson

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 March 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1873-1885

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

Pneumococcal polysaccharide vaccines: Indications, efficacy and recommendations

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

The role of opsonins in recovery from experimental pneumococcal pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Six newly recognized types of Streptococcus pneumoniae.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Streptococcus pneumoniae type 16A, a hitherto undescribed pneumococcal type

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

PNEUMOCOCCAL BACTEREMIA WITH ESPECIAL REFERENCE TO BACTEREMIC PNEUMOCOCCAL PNEUMONIA

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Prevention of Pneumococcal Infection by Immunization with Capsular Polysaccharides of Streptococcus pneumoniae: Current Status of Polyvalent Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Pneumococcal serotypes and their clinical relevance

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Incidence, capsular types, and antibiotic susceptibility of invasive Streptococcus pneumoniae in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Antibody response to pneumococcal vaccination in children younger than five years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

CHEMO-IMMUNOLOGICAL STUDIES ON CONJUGATED CARBOHYDRATE-PROTEINS : V. THE IMMUNOLOGICAL SPECIFITY OF AN ANTIGEN PREPARED BY COMBINING THE CAPSULAR POLYSACCHARIDE OF TYPE III PNEUMOCOCCUS WITH FOREIGN PROTEIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Coupling of acid labile salmonella specific oligosaccharides to macromolecular carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide--pneumolysoid conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Salmonella typhi O-polysaccharide--tetanus toxoid conjugated vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

New vaccines for the prevention of pneumococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Pneumococcal vaccine: time for another controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Electron beam fragmentation of bacterial polysaccharides as a method of producing oligosaccharides for the preparation of conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

A new method of non-cross-linking conjugation of polysaccharides to proteins via thioether bonds for the preparation of saccharide-protein conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Colorimetric Method for Determination of Sugars and Related Substances

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Determination of free amino groups in proteins by trinitrobenzenesulfonic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Tissue sulfhydryl groups

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Specific antibodies to diphtheria toxin and type 6A pneumococcal capsular polysaccharide induced by a model of semi-synthetic glycoconjugate antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Immunogenicity of Streptococcus pneumoniae type 6B and 14 polysaccharide-tetanus toxoid conjugates and the effect of uncoupled polysaccharide on the antigen-specific immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Antibodies to carbohydrates: preparation of antigens by coupling carbohydrates to proteins by reductive amination with cyanoborohydride

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Immunogenicity of a Streptococcus pneumoniae type 4 polysaccharide--protein conjugate vaccine is decreased by admixture of high doses of free saccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Antibody recognition of the type 14 pneumococcal capsule. Evidence for a conformational epitope in a neutral polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Infant immunization with pneumococcal CRM197 vaccines: effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Prospects for the use of new vaccines in developing countries: cost is not the only impediment.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

The epidemiology of pneumococcal disease in infants and children.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Characterization of the cassette containing genes for type 3 capsular polysaccharide biosynthesis in Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

A functional analysis of the Streptococcus pneumoniae genes involved in the synthesis of type 1 and type 3 capsular polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Transmission of Multidrug-Resistant Serotype 23F Streptococcus pneumoniae in Group Day Care: Evidence Suggesting Capsular Transformation of the Resistant Strain In Vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Penicillin-resistant Streptococcus pneumoniae in the Netherlands: results of a 1-year molecular epidemiologic survey

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

Clinical and epidemiologic studies of pneumococcal infection in children

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2899%2900336-9

7 January 2021

10.1016/S0264-410X(99)00336-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10699336%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference